摘要
巴德-吉亚利综合征(Budd-Chiari syndrome,B-CS),又称布-加综合征,是一种严重的肝脏血管疾病,因肝静脉和(或)肝后段下腔静脉狭窄或节段性闭塞导致肝脏淤血,其慢性进展可能导致肝细胞癌的发生。在B-CS治疗的发展过程中,外科手术曾作为主要手段,随着介入技术的不断成熟和肝细胞癌诊疗领域的进展,B-CS相关肝癌的诊治方案也更加多样,对不同分型B-CS、不同期别肝细胞癌的诊疗已形成多学科协作的个体化、规范化、精准化模式。此文通过总结近年来B-CS及肝细胞癌诊疗领域的进展,并结合病例诊治的经验,对B-CS合并HCC的综合诊治进行讨论。
Budd-Chiari syndrome(B-CS)is a severe hepatic vascular disease in which hepatic congestion occurs due to stenosis or segmental occlusion of the hepatic veins and/or posterior hepatic segments,and its chronic progression may lead to the development of hepatocellular carcinoma(HCC).In the development process of B-CS treatment,surgery has been used as the main means.With the continuous maturity of interventional techniques and the progress in the field of diagnosis and treatment of hepatocellular carcinoma,the diagnosis and treatment plan for B-CS-related liver cancer is also more diverse.The diagnosis and treatment of different types of B-CS and different stages of HCC has formed an individualized,standardized and precise mode of multidisciplinary cooperation.In this paper,we discuss the comprehensive diagnosis and treatment of B-CS with HCC by summarizing the progress in the field of B-CS and HCC diagnosis and treatment in recent years,combined with the experience of case diagnosis and treatment.
作者
党晓卫
王培举
李路豪
Dang Xiaowei;Wang Peiju;Li Luhao(Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital of Zhengzhou University,Henan Budd-Chiari Syndrome Diagnosis and Treatment Center,Henan Zhengzhou 450052,China)
出处
《腹部外科》
2020年第4期253-257,共5页
Journal of Abdominal Surgery
关键词
巴德-吉亚利综合征
肝细胞癌
外科手术
介入治疗
Budd-Chiari syndrome
Hepatocellular carcinoma
Surgery
Interventional therapy
